Atlas Trials

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Clinical trial NCT00627666 · COMPLETED

Trial details

NCT number
NCT00627666
Sponsor
Asan Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Start date
2003-01-01
Primary completion
2010-06-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.